Stories about Chemie
- One documentmore
- 3
CO₂ to E-Methanol, Aviation Fuels and Speciality Chemicals: Six Nominees Announced for the “Best CO₂ Utilisation 2026” Innovation Award
One documentmore - 2
Press Release - hubergroup Chemicals launches UHVPI-222200 for high-performance UV-curing coatings
One documentmore Europäischer Rechnungshof - European Court of Auditors
EU:n on edistettävä tehokkaammin maailmanlaajuista ydinturvallisuutta
more- 3
Press Release - hubergroup brings ink system TINKREDIBLE MGA to worldwide markets
One documentmore Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands
Aachen, Germany (ots) - - Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. - Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 ...
more
LAUDA DR. R. WOBSER GMBH & CO. KG
2LAUDA Celebrates Its 70th Anniversary
more- 2
Press release - Aurubis Lünen: Leading-edge plant now producing high-purity oxygen in North Rhine-Westphalia
One documentmore - 4
EU-funded Research Project UNICO₂RN Converts Biogenic CO₂ into Proteins and Bioplastics
One documentmore Sun Chemical selects SNP’s Kyano platform to lead global SAP S/4HANA and RISE with SAP transformation
Heidelberg, Germany I Irving, Texas, USA (ots) - - Sun Chemical consolidates and modernizes its SAP landscape with Kyano - Selective data transformation retains historical data while optimizing structures for SAP S/4HANA - Establishes a cloud-ready digital core for standardized processes and faster insights SNP SE, ...
more- 5
Press Release - hubergroup Chemicals launches ELARA: tailored Additives
One documentmore - 5
CO₂-based Fuels and Chemicals Conference 2026 – Strategic Pathways for Scaling Carbon Capture and Utilisation
One documentmore
- 4
Press Release - hubergroup celebrates one year of success with DYNAMICA at PAMEX 2026
One documentmore - 2
Press Release - hubergroup confirms full GIO compliance for packaging products
One documentmore Henkel kicks off its anniversary year 2026
more- 2
Press Release - hubergroup Chemicals presents expanded portfolio at PAINT INDIA 2026
One documentmore Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small ...
more- 2
Dr. Stefanie Kesting appointed as CEO of Thyssengas
more
In pursuit of its Value Leader Strategy in various Printing Ink markets hubergroup is announcing an inflation correction in its overall pricing to safeguard long-term operational stability & service
morePM: DHL und CMA CGM beschleunigen Dekarbonisierung der Seefracht mit gemeinsamer Biokraftstoffinitiative / PR: DHL and CMA CGM accelerate decarbonization of ocean freight with joint biofuel initiative
2 DocumentsmoreLAUDA DR. R. WOBSER GMBH & CO. KG
LAUDA Once Again Global Market Leader
morePress Release: Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion - Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA - ...
One documentmore- 3
CO₂-based Fuels and Chemicals Conference 2026: Preliminary Program Now Available
One documentmore - 5
Advanced Recycling Conference 2025 Fuels Innovation Across Key Waste Streams
One documentmore
- 4
Call for Innovations Open for CO₂-based Fuels and Chemicals Conference 2026
One documentmore - 4
First climate-positive car trip in history was a complete success
more LTS Lohmann Therapie-Systeme AG
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. With the acquisition, Renaissance facilities will become ...
morePM: DHL und Hapag-Lloyd unterzeichnen Vereinbarung zur weiteren Dekarbonisierung von Lieferketten / PR: DHL and Hapag-Lloyd sign agreement to further decarbonize supply chains
moreEuropäischer Rechnungshof - European Court of Auditors
Läkemedelsbristen är fortfarande en kronisk huvudvärk för EU
moreEuropäischer Rechnungshof - European Court of Auditors
Lääkepula yhä EU:n päänsärkynä
more